Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
- PMID: 25461851
- DOI: 10.1053/j.gastro.2014.11.039
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States
Abstract
Background & aims: Nonalcoholic steatohepatitis (NASH) has been predicted to become the leading indication for liver transplantation (LT) in the United States. However, few studies have evaluated changes in the etiology of liver diseases among patients awaiting LT, and none have focused on the effects of NASH on liver transplant waitlists in the United States.
Methods: We collected data from the United Network for Organ Sharing and Organ Procurement and Transplantation Network registry from 2004 through 2013, on liver transplant waitlist registrants with hepatitis C virus (HCV) infection, NASH, alcoholic liver disease (ALD), or a combination of HCV infection and ALD. We compared differences in survival within 90 days of registration (90-day survival) and probability of LT among patients with different diseases using Kaplan-Meier and multivariate logistic regression models.
Results: Between 2004 and 2013, new waitlist registrants with NASH increased by 170% (from 804 to 2174), with ALD increased by 45% (from 1400 to 2024), and with HCV increased by 14% (from 2887 to 3291); registrants with HCV and ALD decreased by 9% (from 880 to 803). In 2013, NASH became the second-leading disease among liver transplant waitlist registrants, after HCV. Patients with ALD had a significantly higher mean Model for End-Stage Liver Disease score at time of waitlist registration than other registrants. However, after multivariate adjustment, patients with ALD were less likely to die within 90 days when compared with patients with NASH (odds ratio [OR] = 0.77; 95% confidence interval [CI]: 0.67-0.89; P < .001); patients with HCV infection or HCV and ALD had similar odds for 90-day survival compared with NASH patients. Compared with patients with NASH, patients with HCV (OR = 1.45; 95% CI: 1.35-1.55; P < .001), ALD (OR = 1.15; 95% CI: 1.06-1.24; P < .001), or HCV and ALD (OR = 1.29; 95% CI: 1.18-1.42; P < .001) had higher odds for 90-day survival.
Conclusions: Based on data from US adult LT databases, since 2004 the number of adults with NASH awaiting LTs has almost tripled. However, patients with NASH are less likely to undergo LT and less likely to survive for 90 days on the waitlist than patients with HCV, ALD, or HCV and ALD.
Keywords: Fatty Liver; MELD; UNOS/OPTN; Waitlist Mortality.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
The changing liver transplant waitlist: an emerging liver purgatory?Gastroenterology. 2015 Mar;148(3):493-6. doi: 10.1053/j.gastro.2015.01.011. Epub 2015 Jan 19. Gastroenterology. 2015. PMID: 25613312 No abstract available.
Comment on
- Gastroenterology. 2015 Mar;148(3):459-61
Similar articles
-
Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.Dig Dis Sci. 2017 Oct;62(10):2915-2922. doi: 10.1007/s10620-017-4684-x. Epub 2017 Jul 25. Dig Dis Sci. 2017. PMID: 28744836
-
Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.Dig Dis Sci. 2020 May;65(5):1501-1511. doi: 10.1007/s10620-019-05891-1. Epub 2019 Oct 22. Dig Dis Sci. 2020. PMID: 31642005
-
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.Gastroenterology. 2017 Apr;152(5):1090-1099.e1. doi: 10.1053/j.gastro.2017.01.003. Epub 2017 Jan 11. Gastroenterology. 2017. PMID: 28088461 Free PMC article.
-
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?World J Gastroenterol. 2018 Apr 14;24(14):1491-1506. doi: 10.3748/wjg.v24.i14.1491. World J Gastroenterol. 2018. PMID: 29662288 Free PMC article. Review.
-
Liver Transplantation: East versus West.J Clin Exp Hepatol. 2013 Sep;3(3):243-53. doi: 10.1016/j.jceh.2013.08.004. Epub 2013 Sep 12. J Clin Exp Hepatol. 2013. PMID: 25755506 Free PMC article. Review.
Cited by
-
Association between BMI Change, Transaminases, and Other Metabolic Parameters in Children with Nonalcoholic Fatty Liver Disease.J Obes. 2024 May 23;2024:6997280. doi: 10.1155/2024/6997280. eCollection 2024. J Obes. 2024. PMID: 38817395 Free PMC article.
-
Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis.World J Pediatr. 2024 Jun;20(6):569-580. doi: 10.1007/s12519-024-00814-1. Epub 2024 May 21. World J Pediatr. 2024. PMID: 38771552 Review.
-
Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population.Genes (Basel). 2024 Apr 4;15(4):455. doi: 10.3390/genes15040455. Genes (Basel). 2024. PMID: 38674389 Free PMC article.
-
Exercise in the management of metabolic dysfunction-associated fatty liver disease-is more the answer, or is it just one piece of the puzzle?Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):329-332. doi: 10.21037/hbsn-23-686. Epub 2024 Mar 29. Hepatobiliary Surg Nutr. 2024. PMID: 38617488 Free PMC article. No abstract available.
-
Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice.Sci Rep. 2024 Mar 29;14(1):7464. doi: 10.1038/s41598-024-58291-5. Sci Rep. 2024. PMID: 38553537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical